title: Intravitreal injection of recombinant tissue plasminogen activator and pneumatic displacement of submacular haemorrhage.
abstract: We report a case of a patient with hypertension and ischaemic heart disease on anti-platelet treatment, who developed uniocular profound visual loss from a submacular haemorrhage secondary to valsalva retinopathy. He was treated with a combination of intravitreal recombinant tissue plasminogen activator (rtPA) and sulphur hexafluoride (SF6) gas followed by strict prone positioning. He demonstrated significant displacement of the haemorrhage and improvement of vision postoperatively.
authors: Department of Ophthalmology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur. drnfm@yahoo.com
authors: M
authors: M
authors: Fadhilah
authors: Z
authors: Z
authors: Mimiwati
authors: K C S
authors: KC
authors: Fong
mesh_terms: D006801:Humans; D058449:Intravitreal Injections; D008266:Macula Lutea; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage; D012166:Retinal Hemorrhage / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator